These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28003247)

  • 1. Impaired High-Density Lipoprotein Anti-Oxidative Function Is Associated With Outcome in Patients With Chronic Heart Failure.
    Schrutka L; Distelmaier K; Hohensinner P; Sulzgruber P; Lang IM; Maurer G; Wojta J; Hülsmann M; Niessner A; Koller L
    J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 28003247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired High-Density Lipoprotein Anti-Oxidant Function Predicts Poor Outcome in Critically Ill Patients.
    Schrutka L; Goliasch G; Meyer B; Wurm R; Koller L; Kriechbaumer L; Heinz G; Pacher R; Lang IM; Distelmaier K; Hülsmann M
    PLoS One; 2016; 11(3):e0151706. PubMed ID: 26978526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-oxidant HDL predicts poor outcome in patients with ST-elevation acute coronary syndrome.
    Distelmaier K; Schrutka L; Seidl V; Winter M; Wurm R; Mangold A; Perkmann T; Maurer G; Adlbrecht C; Lang IM
    Thromb Haemost; 2015 Jul; 114(1):133-8. PubMed ID: 25831998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired High-Density Lipoprotein Function in Patients With Heart Failure.
    Emmens JE; Jia C; Ng LL; van Veldhuisen DJ; Dickstein K; Anker SD; Lang CC; Filippatos G; Cleland JGF; Metra M; Voors AA; de Boer RA; Tietge UJF
    J Am Heart Assoc; 2021 May; 10(9):e019123. PubMed ID: 33870728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-related impact on outcomes of high density lipoprotein in acute ST-elevation myocardial infarction.
    Distelmaier K; Schrutka L; Wurm R; Seidl V; Arfsten H; Cho A; Manjunatha S; Perkmann T; Strunk G; Lang IM; Adlbrecht C
    Atherosclerosis; 2016 Aug; 251():460-466. PubMed ID: 27381657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The predictive value of the antioxidative function of HDL for cardiovascular disease and graft failure in renal transplant recipients.
    Leberkühne LJ; Ebtehaj S; Dimova LG; Dikkers A; Dullaart RP; Bakker SJ; Tietge UJ
    Atherosclerosis; 2016 Jun; 249():181-5. PubMed ID: 27107804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Von Willebrand factor improves risk prediction in addition to N-terminal pro-B-type natriuretic peptide in patients referred to coronary angiography and signs and symptoms of heart failure and preserved ejection fraction.
    Kleber ME; Koller L; Goliasch G; Sulzgruber P; Scharnagl H; Silbernagel G; Grammer TB; Delgado G; Tomaschitz A; Pilz S; März W; Niessner A
    Circ Heart Fail; 2015 Jan; 8(1):25-32. PubMed ID: 25342739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immature surfactant protein-B impairs the antioxidant capacity of HDL.
    Banfi C; Brioschi M; Karjalainen MK; Huusko JM; Gianazza E; Agostoni P
    Int J Cardiol; 2019 Jun; 285():53-58. PubMed ID: 30857841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.
    Duprez DA; Otvos J; Tracy RP; Feingold KR; Greenland P; Gross MD; Lima JA; Mackey RH; Neaton JD; Sanchez OA; Jacobs DR
    J Am Heart Assoc; 2015 Sep; 4(9):e002295. PubMed ID: 26370448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Survival and Apolipoprotein A1 Level in Chronic Heart Failure: Interaction With Tumor Necrosis Factor α -308 G/A Polymorphism.
    Gombos T; Förhécz Z; Pozsonyi Z; Jánoskuti L; Prohászka Z; Karádi I
    J Card Fail; 2017 Feb; 23(2):113-120. PubMed ID: 27317841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-density lipoprotein subclass profile and mortality in patients with coronary artery disease: Results from the GENES study.
    Elbaz M; Faccini J; Bongard V; Ingueneau C; Taraszkiewicz D; Perret B; Ferrières J; Ruidavets JB; Vindis C
    Arch Cardiovasc Dis; 2016 Nov; 109(11):607-617. PubMed ID: 27693051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP.
    Bayes-Genis A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Gastelurrutia P; Vila J; Peñafiel J; Gálvez-Montón C; Lupón J
    Rev Esp Cardiol (Engl Ed); 2015 Dec; 68(12):1075-84. PubMed ID: 26297179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired antioxidative activity of high-density lipoprotein is associated with more severe acute ischemic stroke.
    Tziomalos K; Katrini K; Papagianni M; Christou K; Gkolfinopoulou C; Angelopoulou SM; Sofogianni A; Savopoulos C; Hatzitolios AI; Chroni A
    Metabolism; 2019 Sep; 98():49-52. PubMed ID: 31202834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis.
    Hussein H; Saheb S; Couturier M; Atassi M; Orsoni A; Carrié A; Therond P; Chantepie S; Robillard P; Bruckert E; Chapman MJ; Kontush A
    J Clin Lipidol; 2016; 10(1):124-33. PubMed ID: 26892129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure.
    Masci PG; Doulaptsis C; Bertella E; Del Torto A; Symons R; Pontone G; Barison A; Droogné W; Andreini D; Lorenzoni V; Gripari P; Mushtaq S; Emdin M; Bogaert J; Lombardi M
    Circ Heart Fail; 2014 May; 7(3):448-56. PubMed ID: 24647118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prealbumin improves death risk prediction of BNP-added Seattle Heart Failure Model: results from a pilot study in elderly chronic heart failure patients.
    Cabassi A; de Champlain J; Maggiore U; Parenti E; Coghi P; Vicini V; Tedeschi S; Cremaschi E; Binno S; Rocco R; Bonali S; Bianconcini M; Guerra C; Folesani G; Montanari A; Regolisti G; Fiaccadori E
    Int J Cardiol; 2013 Oct; 168(4):3334-9. PubMed ID: 23623341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-density lipoprotein-associated paraoxonase-1 activity for prediction of adverse outcomes in outpatients with chronic heart failure.
    Hammadah M; Kalogeropoulos AP; Georgiopoulou VV; Weber M; Wu Y; Hazen SL; Butler J; Tang WHW
    Eur J Heart Fail; 2017 Jun; 19(6):748-755. PubMed ID: 28176482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic relevance of circulating endothelial progenitor cells in patients with chronic heart failure.
    Koller L; Hohensinner P; Sulzgruber P; Blum S; Maurer G; Wojta J; Hülsmann M; Niessner A
    Thromb Haemost; 2016 Aug; 116(2):309-16. PubMed ID: 27412580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-density lipoprotein cholesterol levels and prognosis in advanced heart failure.
    Mehra MR; Uber PA; Lavie CJ; Milani RV; Park MH; Ventura HO
    J Heart Lung Transplant; 2009 Sep; 28(9):876-80. PubMed ID: 19716038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.